Hypertrophic cardiomyopathy: Value of atrial programmed electrical stimulation in patients with or without syncope with special reference to the role of atrial arrhythmias

被引:6
作者
BrembillaPerrot, B
Jacquot, A
Beurrier, D
Jacquemin, L
机构
[1] Cardiologie A, CHU of Brabois
关键词
hypertrophic cardiomyopathy; programmed atrial stimulation; atrial fibrillation;
D O I
10.1016/S0167-5273(96)02900-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy may be associated with both supraventricular and ventricular arrhythmias, which may play a role in the genesis of syncope. The aim of this study was to assess the findings of electrophysiological study and programmed atrial and ventricular stimulation and their possible role in syncope. Programmed atrial and ventricular stimulation using up to two extrastimuli in right atrium and three in right ventricle at three cycle lengths (600, 400 ms and spontaneous) was systematically performed in 56 patients with hypertrophic cardiomyopathy. Thirty seven had unexplained dizzinesses or syncopes (group I) and 19 did not present loss of consciousness (group Il). Patients with syncopes had a higher prevalence of induced sustained supraventricular tachyarrhythmia (73%) than those of group II (16%) (P<0.05). Inducible supraventricular tachycardia was the only finding in 16 patients with syncopes. During the follow-up (3 years+/-6 months), empirical antiarrhythmic therapy suppressed the symptoms, except in two patients who developed atrial fibrillation despite therapy. The high incidence of inducible atrial tachycardia of these patients was not correlated with particular Holter findings or echocardiographic data. However, their mean age was rather high (58+/-12 years). In conclusion, atrial tachyarrhythmias may play a role in syncopes of middle-aged patients with hypertrophic cardiomyopathy. Moreover programmed atrial stimulation is an useful means to identify this syncope mechanism. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 37 条
[1]   SYNCOPE AND SUDDEN-DEATH IN HYPERTROPHIC CARDIOMYOPATHY [J].
BRANDENBURG, RO .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (05) :962-964
[2]   DIAGNOSTIC-VALUE OF VENTRICULAR STIMULATION IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY [J].
BREMBILLAPERROT, B ;
DONETTI, J ;
DELACHAISE, AT ;
SADOUL, N ;
ALIOT, E ;
JUILLIERE, Y .
AMERICAN HEART JOURNAL, 1991, 121 (04) :1124-1131
[3]  
BREMBILLAPERROT B, 1989, BRIT HEART J, V61, P348
[4]   INCIDENCE AND SIGNIFICANCE OF INDUCIBLE SUPRAVENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH CHRONIC MYOCARDIAL-INFARCTION [J].
BREMBILLAPERROT, B ;
DELACHAISE, AT ;
DESOUZA, ML ;
BAILLY, L .
EUROPEAN HEART JOURNAL, 1991, 12 (03) :401-404
[5]  
BREMBILLAPERROT B, 1992, EUR HEART J, V13, P483
[6]   INFLUENCE OF BASIC ATRIAL RHYTHM ON INTRAATRIAL CONDUCTION OF EXTRASTIMULI [J].
COSIO, FG ;
PAYLOS, J ;
REQUENA, M ;
FERNANDEZYANEZ, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (08) :1018-1021
[7]   VERAPAMIL - ITS POTENTIAL FOR CAUSING SERIOUS COMPLICATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY [J].
EPSTEIN, SE ;
ROSING, DR .
CIRCULATION, 1981, 64 (03) :437-441
[8]   ELECTROPHYSIOLOGIC ABNORMALITIES IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - A CONSECUTIVE ANALYSIS IN 155 PATIENTS [J].
FANANAPAZIR, L ;
TRACY, CM ;
LEON, MB ;
WINKLER, JB ;
CANNON, RO ;
BONOW, RO ;
MARON, BJ ;
EPSTEIN, SE .
CIRCULATION, 1989, 80 (05) :1259-1268
[9]   IMPACT OF DUAL-CHAMBER PERMANENT PACING IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY WITH SYMPTOMS REFRACTORY TO VERAPAMIL AND BETA-ADRENERGIC BLOCKER THERAPY [J].
FANANAPAZIR, L ;
CANNON, RO ;
TRIPODI, D ;
PANZA, JA .
CIRCULATION, 1992, 85 (06) :2149-2161
[10]   PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY - PROSPECTIVE EVALUATION OF A THERAPEUTIC STRATEGY BASED ON CLINICAL, HOLTER, HEMODYNAMIC, AND ELECTROPHYSIOLOGICAL FINDINGS [J].
FANANAPAZIR, L ;
CHANG, AC ;
EPSTEIN, SE ;
MCAREAVEY, D .
CIRCULATION, 1992, 86 (03) :730-740